AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34654579 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality intervention (consultation with a general practitioner)
Number of subjects: 507
Study 34654579 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality intervention (communication of personal benefits only)
Number of subjects: 507
Study 34654579 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality intervention (communication of personal and collective benefits)
Number of subjects: 507
Study 33959179 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care program
Number of subjects: 60
Study 33959179 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 60
Study 32069126 — intervention group
Group type: EXPERIMENTAL
Intervention: Etonogestrel-releasing subdermal implant
Number of subjects: 103
Study 32069126 — intervention group
Group type: COMPARATOR
Intervention: 52-mg levonorgestrel-releasing intrauterine system
Number of subjects: 103
Study 36371675 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia (propofol maintenance)
Number of subjects: 175
Study 36371675 — intervention group
Group type: COMPARATOR
Intervention: Inhalation anesthesia (sevoflurane maintenance)
Number of subjects: 175
Study 36371675 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergence delirium
Number of subjects: 175
Study 33414377 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Training (MIT)
Number of subjects: 22
Study 33414377 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint Intensity Training (SIT)
Number of subjects: 22
Study 33414377 — intervention group
Group type: COMPARATOR
Intervention: Both MIT and SIT
Number of subjects: 22
Study 36271356 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser guiding navigation device
Number of subjects: 32
Study 36271356 — intervention group
Group type: COMPARATOR
Intervention: Freehand technique
Number of subjects: 32
Study 33459901 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal-related events (SRE) patients
Number of subjects: 9832
Study 33459901 — intervention group
Group type: COMPARATOR
Intervention: Non-skeletal-related events (non-SRE) patients
Number of subjects: 9832
Study 34435212 — intervention group
Group type: EXPERIMENTAL
Intervention: Ostomy Self-Management Telehealth (OSMT)
Number of subjects: 118
Study 34435212 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 118
Study 32609532 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained hypoxia (SH)
Number of subjects: 35
Study 32609532 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (IH)
Number of subjects: 35
Study 32609532 — intervention group
Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 35
Study 35412685 — intervention group
Group type: EXPERIMENTAL
Intervention: N. sativa oil (two capsules of 500 mg)
Number of subjects: 50
Study 35412685 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two capsules of 500 mg mineral oil)
Number of subjects: 50
Study 34314574 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (10 mg/day for creatinine clearance ≥50 ml/min; 7.5 mg/day for ≥30-<50 ml/min)
Number of subjects: 0
Study 34314574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34314574 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban and Placebo
Number of subjects: 0
Study 35871989 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching Group
Number of subjects: 49
Study 35871989 — intervention group
Group type: COMPARATOR
Intervention: No Coaching Group
Number of subjects: 49
Study 34570899 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined blast and blunt head trauma
Number of subjects: 190
Study 34570899 — intervention group
Group type: COMPARATOR
Intervention: Blunt trauma only
Number of subjects: 190
Study 34570899 — intervention group
Group type: COMPARATOR
Intervention: Blast trauma only
Number of subjects: 190
Study 36008267 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents
Number of subjects: 1498
Study 36008267 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 1498
Study 35468455 — intervention group
Group type: EXPERIMENTAL
Intervention: ALARA approach
Number of subjects: 61
Study 35468455 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 61
Study 32032641 — intervention group
Group type: EXPERIMENTAL
Intervention: Online group including IUD users
Number of subjects: 488
Study 32032641 — intervention group
Group type: COMPARATOR
Intervention: Control group including nine IUD non-users
Number of subjects: 488
Study 34056945 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) combined with high-density fat transplantation
Number of subjects: 70
Study 34056945 — intervention group
Group type: COMPARATOR
Intervention: Conventional fat-granule transplantation (control group)
Number of subjects: 70
Study 33428798 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous maize cultivation for 1-9 years in areas surrounding problem fields
Number of subjects: 0
Study 33428798 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous maize cultivation from 2003 to 2018
Number of subjects: 0
Study 33428798 — intervention group
Group type: COMPARATOR
Intervention: Geospatial analysis of land use patterns
Number of subjects: 0
Study 36171515 — intervention group
Group type: EXPERIMENTAL
Intervention: IV golimumab 80 mg/m2 at weeks 0, 4, then every 8 weeks (Q8W)
Number of subjects: 127
Study 36171515 — intervention group
Group type: EXPERIMENTAL
Intervention: SC ustekinumab at weeks 0, 4, then Q12W (dosing based on weight)
Number of subjects: 127
Study 34622669 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stents (DES)
Number of subjects: 26024
Study 34622669 — intervention group
Group type: COMPARATOR
Intervention: Bare-Metal Stents (BMS)
Number of subjects: 26024
Study 32629662 — intervention group
Group type: EXPERIMENTAL
Intervention: Yizhi Qingxin Decoction (YQD)
Number of subjects: 100
Study 32629662 — intervention group
Group type: COMPARATOR
Intervention: Ginkgo biloba extract tablets
Number of subjects: 100
Study 32930627 — intervention group
Group type: EXPERIMENTAL
Intervention: TCHMC 200 g per day
Number of subjects: 18
Study 32930627 — intervention group
Group type: EXPERIMENTAL
Intervention: TCHMC 300 g per day
Number of subjects: 18
Study 32930627 — intervention group
Group type: COMPARATOR
Intervention: Control group (0 g TCHMC per day)
Number of subjects: 18
Study 33397121 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization approach
Number of subjects: 0
Study 35997868 — intervention group
Group type: EXPERIMENTAL
Intervention: Facility-based HIV testing augmented with free HIV self-testing (HIVST)
Number of subjects: 230
Study 35997868 — intervention group
Group type: COMPARATOR
Intervention: Facility-based HIV testing
Number of subjects: 230
Study 34433576 — intervention group
Group type: EXPERIMENTAL
Intervention: High-definition transcranial direct current stimulation (HD-tDCS) above the medial prefrontal cortex (mPFC)
Number of subjects: 103
Study 34433576 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 103
Study 34433576 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-tDCS
Number of subjects: 103
Study 35083623 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: video laryngoscopes with a self‐equipped stylet for tube preshaping
Number of subjects: 300
Study 35083623 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: curvature of the video laryngoscope blade is modelled for tube preshaping
Number of subjects: 300
Study 35083623 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: tube preshaping angle consistent with the video laryngoscope blade, bending point set 1 cm above the tracheal tube cuff
Number of subjects: 300
Study 35083623 — intervention group
Group type: COMPARATOR
Intervention: Group A
Number of subjects: 300
Study 35083623 — intervention group
Group type: COMPARATOR
Intervention: Group B
Number of subjects: 300
Study 34244277 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help intervention (EG) based on Acceptance and Commitment Therapy (ACT), comprising an introduction and seven modules (one module per week, processing time about 45-60 min).
Number of subjects: 42
Study 34244277 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (CG).
Number of subjects: 42
Study 35176765 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of gastrointestinal (GI) symptoms in adults (34.1%)
Number of subjects: 2370
Study 35176765 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher hemoglobin A1c (HbA1c) levels in patients with GI symptoms (68 ± 14mmol/mol; 8.35 ± 1.37%)
Number of subjects: 2370
Study 35176765 — intervention group
Group type: EXPERIMENTAL
Intervention: Microvascular complications (nephropathy, retinopathy, and/or neuropathy)
Number of subjects: 2370
Study 35176765 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of autoimmune conditions (including thyroid and biopsy‐confirmed celiac disease)
Number of subjects: 2370
Study 33678469 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 266
Study 33678469 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 266
Study 32184007 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoral nerve (Pecs) II block under general anesthesia (PG group)
Number of subjects: 196
Study 32184007 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone (G group)
Number of subjects: 196
Study 36151754 — intervention group
Group type: EXPERIMENTAL
Intervention: OSCE group (n=19)
Number of subjects: 38
Study 36151754 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=19)
Number of subjects: 38
Study 33615395 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet + 0.15 mg Se/kg (NS-Gly)
Number of subjects: 864
Study 33615395 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet + 0.30 mg Se/kg (NS-Gly)
Number of subjects: 864
Study 33615395 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet + 0.45 mg Se/kg (NS-Gly)
Number of subjects: 864
Study 33615395 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet + 0.60 mg Se/kg (NS-Gly)
Number of subjects: 864
Study 33615395 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet + 0.30 mg Se/kg (Na2SeO3)
Number of subjects: 864
Study 33615395 — intervention group
Group type: COMPARATOR
Intervention: Basal diet (control, 0.13 mg Se/kg)
Number of subjects: 864
Study 33142505 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural astaxanthin (ASTA) 25 mg/kg
Number of subjects: 288
Study 33142505 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural astaxanthin (ASTA) 50 mg/kg
Number of subjects: 288
Study 33142505 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural astaxanthin (ASTA) 100 mg/kg
Number of subjects: 288
Study 33142505 — intervention group
Group type: COMPARATOR
Intervention: Control (0 mg/kg ASTA)
Number of subjects: 288
Study 36052911 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvest technique
Number of subjects: 80
Study 36052911 — intervention group
Group type: COMPARATOR
Intervention: Conventional vein harvest technique
Number of subjects: 80
Study 33316237 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-limb LLHR-RT
Number of subjects: 33
Study 33316237 — intervention group
Group type: COMPARATOR
Intervention: Two-limb LLHR-RT
Number of subjects: 33
Study 36129031 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital (0.5 mg/kg)
Number of subjects: 70
Study 36129031 — intervention group
Group type: COMPARATOR
Intervention: Propofol (0.8 mg/kg)
Number of subjects: 70
Study 33153433 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative age stereotype priming (n=53)
Number of subjects: 105
Study 33153433 — intervention group
Group type: COMPARATOR
Intervention: Neutral words priming (n=52)
Number of subjects: 105
Study 33153433 — intervention group
Group type: EXPERIMENTAL
Intervention: Social participation (moderating factor)
Number of subjects: 105
Study 35614276 — intervention group
Group type: EXPERIMENTAL
Intervention: A-PRF+
Number of subjects: 16
Study 35614276 — intervention group
Group type: COMPARATOR
Intervention: Blood clot (Control)
Number of subjects: 16
Study 32739493 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person advance care planning (ACP) discussions via face-to-face visits with a nurse facilitator following the Respecting Choices® Conversation Guide
Number of subjects: 0
Study 32739493 — intervention group
Group type: COMPARATOR
Intervention: Web-based ACP using the PREPARE for your care™ web-based ACP tool
Number of subjects: 0
Study 32557166 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low dose CT (ULDCT)
Number of subjects: 325
Study 32557166 — intervention group
Group type: COMPARATOR
Intervention: Contrast-enhanced CT (CECT)
Number of subjects: 325
Study 35709575 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended training (ET)
Number of subjects: 321
Study 35709575 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 321
Study 35709575 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended training with significant other (ETwSO)
Number of subjects: 321
Study 35709575 — intervention group
Group type: EXPERIMENTAL
Intervention: All training conditions
Number of subjects: 321
Study 32472340 — intervention group
Group type: EXPERIMENTAL
Intervention: Essix retainers
Number of subjects: 35
Study 32472340 — intervention group
Group type: COMPARATOR
Intervention: Hawley retainers
Number of subjects: 35
Study 32472340 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Essix and Hawley retainers
Number of subjects: 35
Study 36494702 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention (n=112)
Number of subjects: 219
Study 36494702 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=107)
Number of subjects: 219
Study 36494702 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory analysis
Number of subjects: 219
Study 32556518 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 400 IU/day
Number of subjects: 302
Study 32556518 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 4000 IU/day
Number of subjects: 302
Study 32556518 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 10,000 IU/day
Number of subjects: 302
Study 35221758 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/kg
Number of subjects: 162
Study 35221758 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.0 μg/kg
Number of subjects: 162
Study 35221758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 32028459 — intervention group
Group type: EXPERIMENTAL
Intervention: HRRT-2 (2 days per week)
Number of subjects: 0
Study 32028459 — intervention group
Group type: EXPERIMENTAL
Intervention: HRRT-3 (3 days per week)
Number of subjects: 0
Study 32759621 — intervention group
Group type: EXPERIMENTAL
Intervention: Ileal ulcers >2 cm
Number of subjects: 172
Study 32759621 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal ulcers >2 cm
Number of subjects: 172
Study 32759621 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep ileal ulcers >2 cm
Number of subjects: 172
Study 32759621 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep rectal ulcers >2 cm
Number of subjects: 172
Study 32759621 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline Simple Endoscopic Score for CD (≥16) or CDEIS scores (≥12)
Number of subjects: 172
Study 35172663 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E + Omega 3 supplementation for 3 months
Number of subjects: 0
Study 35172663 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33722073 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy plus fluoxetine
Number of subjects: 153
Study 33722073 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioural therapy plus placebo
Number of subjects: 153
Study 32785972 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of nitric oxide synthase inhibitor NG‐monomethyl‐l‐arginine (l‐NMMA, 5 mg kg−1 bolus & subsequent 50 μg kg−1 min−1 maintenance dose)
Number of subjects: 18
Study 32785972 — intervention group
Group type: COMPARATOR
Intervention: Isovolumic haemodilution (20% of whole blood removed and replaced with 5% human serum albumin)
Number of subjects: 18
Study 32785972 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine infusion (0.1–0.6 μg kg−1 min−1 constant infusion)
Number of subjects: 18
Study 32197901 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulation at discharge
Number of subjects: 166747
Study 32197901 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone use at discharge without anticoagulation
Number of subjects: 166747
Study 32144499 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) model with VGG16 architecture
Number of subjects: 68
Study 32144499 — intervention group
Group type: COMPARATOR
Intervention: Traditional machine learning method using Support Vector Machine (SVM)
Number of subjects: 68
Study 35902979 — intervention group
Group type: EXPERIMENTAL
Intervention: PL‐MSCs intravenous injection (1 × 10^6 cells/kg)
Number of subjects: 20
Study 35902979 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment + PL‐MSCs
Number of subjects: 20
Study 35902979 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 20
Study 33231127 — intervention group
Group type: EXPERIMENTAL
Intervention: Triggered monitoring (risk-based monitoring method)
Number of subjects: 312
Study 33231127 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralised processes for detecting or preventing findings
Number of subjects: 312
Study 33231127 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent processes
Number of subjects: 312
Study 33231127 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of electronic health records
Number of subjects: 312
Study 33039490 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossroads (2001-2003)
Number of subjects: 5258
Study 33039490 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossroads-II (2016-2018)
Number of subjects: 5258
Study 36333495 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (4000 IU/day)
Number of subjects: 50
Study 36333495 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (4000 IU/day) combined with exercise
Number of subjects: 50
Study 36333495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 35227308 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial treatment
Number of subjects: 4792
Study 35227308 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay in antimicrobials
Number of subjects: 4792
Study 35227308 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to surgical source control
Number of subjects: 4792
Study 35227308 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay of source control
Number of subjects: 4792
Study 33301579 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment failure
Number of subjects: 140
Study 33301579 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated C-reactive protein level
Number of subjects: 140
Study 33301579 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of stay (LOS)
Number of subjects: 140
Study 33301579 — intervention group
Group type: EXPERIMENTAL
Intervention: Univariate analysis
Number of subjects: 140
Study 34802446 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) intervention
Number of subjects: 155
Study 34802446 — intervention group
Group type: COMPARATOR
Intervention: Wait list control condition
Number of subjects: 155
Study 33164955 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual care training program
Number of subjects: 73
Study 33164955 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 73
Study 33387509 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab alone
Number of subjects: 0
Study 33387509 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab plus tremelimumab
Number of subjects: 0
Study 33387509 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study 32035222 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance followed by resistance training (E + R; n = 10)
Number of subjects: 30
Study 32035222 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance followed by endurance training (R + E; n = 10)
Number of subjects: 30
Study 32035222 — intervention group
Group type: COMPARATOR
Intervention: Control (C; n = 10)
Number of subjects: 30
Study 33559259 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 11
Study 33559259 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol propionate (0.05%)
Number of subjects: 11
Study 32468174 — intervention group
Group type: EXPERIMENTAL
Intervention: Uphold™ hysteropexy (HP)
Number of subjects: 101
Study 32468174 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy (VH)
Number of subjects: 101
Study 34461078 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (enoxaparin; 40 mg subcutaneously)
Number of subjects: 33
Study 34461078 — intervention group
Group type: COMPARATOR
Intervention: Control group (no low-molecular-weight heparin)
Number of subjects: 33
Study 32049831 — intervention group
Group type: EXPERIMENTAL
Intervention: sugammadex 2 mg/kg
Number of subjects: 60
Study 32049831 — intervention group
Group type: COMPARATOR
Intervention: pyridostigmine 0.2 mg/kg plus glycopyrrolate 0.01 mg/kg
Number of subjects: 60
Study 33980610 — intervention group
Group type: EXPERIMENTAL
Intervention: Pac-S-1 (paclitaxel + S-1)
Number of subjects: 499
Study 33980610 — intervention group
Group type: EXPERIMENTAL
Intervention: Pac-UFT (paclitaxel + UFT)
Number of subjects: 499
Study 33980610 — intervention group
Group type: EXPERIMENTAL
Intervention: Pac-Ram (paclitaxel + ramucirumab)
Number of subjects: 499
Study 34534048 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl prior to colonoscopy
Number of subjects: 539
Study 34534048 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl on-demand
Number of subjects: 539
Study 34534048 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil on-demand
Number of subjects: 539
Study 35271609 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics
Number of subjects: 175
Study 35271609 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 175